Abstract:BACKGROUND:Membrane protein GP90 of China equine infectious anemia virus (EIAV) vaccine strain (DLV) and its parental wild type LN strain were expressed with Bac-to-Bac baculovirus expression system and BALB/c mice were inoculated with purified protein, thereby to explore the availability of protein for differential diagnosis and potential for preparing genetically engineered vaccine.METHODS:The authors infected donkey PBMC culture with China EIAV vaccine strain (DLV) and its parental wild type LN strain, extracted its proviral DNA as template, amplified the GP90 of DLV and LN, respectively, and expressed with Bac-to-Bac baculovirus expression system. The sf9 insect cells were infected with the recombinant baculovirus and the expressed proteins were purified by IMAC. BALB/c mice were inoculated with purified protein. The specific binding Abs generated in the immunized mice were determined by ELISA method. The neutralizing assay was set up to determine the neutralizing capability of the antigens generated in immunized animals.RESULTS:The recombinant virus expressing viral antigens was determined by Western blot. The expressed proteins were purified by IMAC resulting in the protein purity of 87%(DLV) and 82%(LN), respectively. The antibody titer of the groups with and without adjuvant was 1 600 and 800, respectively. Serial 2 fold dilutions of the immunized mice sera were reacted with 100 TCID50 of EIAV. The end point of immunization assay was to protect 50% cells form CPE caused by EIAV in donkey skin cells. The neutralizing antibody titer was in the range 40 to 80 from animal immunized with and without adjuvant.CONCLUSIONS:Membrane proteins of EIAV vaccine strain and wild type strain were successfully expressed in eukaryotic cell expression system according to the scheduled plan. The proteins showed strong immunogenicity and could activate animals to produce anti-EIAV specific antibody including neutralizing antibody to EIAV.

Kinetics of Humoral Immune Responses Induced by an Infectious Clone Derived from an Attenuated EIAV Vaccine.

A Pilot Study on an Attenuated Chinese EIAV Vaccine Inducing Broadly Neutralizing Antibodies

[Induction of EIAV-specific Cellular Immune Response by Attenuated EIAV Vaccine].

An Attenuated EIAV Vaccine Strain Induces Significantly Different Immune Responses from Its Pathogenic Parental Strain Although with Similar in Vivo Replication Pattern

Amino Acid Mutations of the Infectious Clone from Chinese EIAV Attenuated Vaccine Resulted in Reversion of Virulence.

Elevation of IL-2 Expressing Level in PBMC of EIAV Vaccinated Horses

[Expression and Immunogenicity of Equine Infectious Anemia Virus Membrane Protein GP90].

In vivo evolution of the gp90 gene and consistently low plasma viral load during transient immune suppression demonstrate the safety of an attenuated equine infectious anemia virus (EIAV) vaccine

Transient Immune Suppression of Inapparent Carrier Ponies Inoculated with Attenuated Equine Infectious Anemia Virus Infectious Clone.

[A Flow Cytometric Assay for the Expression of Interferon Gamma in T Lymphocytes and Its Application in the Study of EIAV-induced Immune Response].

A Pilot Study Comparing the Development of EIAV Env-Specific Antibodies Induced by DNA/Recombinant Vaccinia-Vectored Vaccines and an Attenuated Chinese EIAV Vaccine

Construction of an Infectious Clone Within the V3 Region of Gp90 Surface Protein of EIAV by N-glycosylation Revers-mutations

Construction of an Infectious Clone Within the V4 Region of Gp90 Surface Protein of EIAV by N-glycosylation Revers-Mutations

Combined immunity of DNA vector and recombinant vaccinia virus expressing Gag proteins of equine infectious anemia virus

Cloning and sequencing of the full genome of equine infectious anemia virus provirus DNA

In Vivo Evolution of Gag and Gp45 Genes of Equine Infectious Anemia Virus

Development and Application of an Indirect ELISA for the Detection of Gp45 Antibodies to Equine Infectious Anemia Virus

[Elevation of IFN-gamma Transcription Level in Peripheral Blood Mononuclear Cells of EIAV Vaccinated Horses].

Amino Acid Mutations in the Env Gp90 Protein That Modify N-linked Glycosylation of the Chinese EIAV Vaccine Strain Enhance Resistance to Neutralizing Antibodies.

Combined amino acid mutations occurring in the envelope closely correlate with pathogenicity of EIAV

A platform for the rapid screening of equine immunoglobins F (ab)2 derived from single equine memory B cells able to cross-neutralize to influenza virus